CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Twin Lakes Capital Management, LLC's Holding History (CIK: 0001847794)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 682 Value ($000) $36 Avg Close $59.89 Range $48.02 - $78.48
Q3 2025
Shares 682 Value ($000) $44 Avg Close $57.41 Range $46.60 - $71.13
Q2 2025
Shares 682 Value ($000) $33 Avg Close $38.70 Range $30.04 - $51.52
Q1 2025
Shares 682 Value ($000) $23 Avg Close $42.39 Range $32.96 - $55.88
Q4 2024
Shares 682 Value ($000) $27 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 682 Value ($000) $32 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 682 Value ($000) $37 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 682 Value ($000) $46 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 682 Value ($000) $43 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 682 Value ($000) $31 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 682 Value ($000) $38 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 772 Value ($000) $35 Avg Close $48.57 Range $39.88 - $58.50
Q4 2022
Shares 772 Value ($000) $31 Avg Close $53.05 Range $38.94 - $66.31
Q3 2022
Shares 772 Value ($000) $50 Avg Close $72.47 Range $60.41 - $86.95
Q1 2022
Shares 772 Value ($000) $48 Avg Close $62.79 Range $50.54 - $79.40
Q4 2021
Shares 428 Value ($000) $32 Avg Close $87.36 Range $67.15 - $112.39
Q3 2021
Shares 428 Value ($000) $48 Avg Close $125.59 Range $109.63 - $163.00
Q2 2021
Shares 428 Value ($000) $69 Avg Close $121.62 Range $95.11 - $169.76
Q1 2021
Shares 428 Value ($000) $52 Avg Close $151.00 Range $100.00 - $220.20